BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1155@pharmaconomics
DTSTAMP:20260707T031156Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:BLTE PDUFA — tinlarebant (estimated date)
DESCRIPTION:The FDA's approval decision on tinlarebant for Stargardt disease type 1 is due ~ Jun 30\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1889109/000110465926064049/tm2614933d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/1155
URL:https://pharmaconomics.com/e/1155
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:BLTE catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR